Association of GLP-1 receptor agonist use with long-term outcomes in patients with opioid use disorder
< 0.001. These findings suggest that GLP-1RA use was associated with lower mortality, overdose risk, and healthcare utilization, supporting further investigation of GLP-1RAs as potential adjunctive therapies for OUD.
Authors
- Dhairya A. Lakhani (ORCID: https://orcid.org/0000-0001-7577-1887)
- Wanhong Zheng (ORCID: https://orcid.org/0000-0003-3262-2720)
Institutions
- West Virginia University (US)
- Blanchette Rockefeller Neurosciences Institute (US)
- Rockefeller University (US)
Publication Details
- Journal
- Journal of Addictive Diseases
- Published
- 2026-05-11
- DOI
- https://doi.org/10.1080/10550887.2026.2653228
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute of General Medical Sciences